Palisade Bio, Inc. (PALI) Stock Grade

About Palisade Bio, Inc.'s fundamentals

Palisade Bio is a biotechnology company with a market capitalization of $130.8 million that reported zero revenue growth year-over-year and a net loss in its latest annual statement. The company currently has no dividend yield and maintains a net margin of 0.0%, indicating it is not yet profitable. With no meaningful revenue generation and negative net income, traditional valuation metrics like the P/E ratio and return on equity are not applicable to the company's current financial position.